88 related articles for article (PubMed ID: 10977930)
1. Immunotoxicological characteristics of preparations based on carcinoembryonic antigen and mucin containing CA 125 antigen.
Sitdikova SM; Amandzholov BS; Sel'chuk VY; Kormosh NG; Laktionov KP; Lebedin YS; Chukanov SV; Toptygin AY; Manzyuk LV; Donenko FV
Bull Exp Biol Med; 2000 Apr; 129(4):389-91. PubMed ID: 10977930
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of specific immunotherapy with mucin containing CA 125 antigen in mice with CaO 1 ovarian carcinoma.
Amandzholov BS; Sitdikova SM; Lebedin YS; Chukanov SV; Toptygin AY; Manzyuk LV; Donenko FV
Bull Exp Biol Med; 2000 Apr; 129(4):383-5. PubMed ID: 10977928
[TBL] [Abstract][Full Text] [Related]
3. Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4.
Gold DV; Alisauskas R; Sharkey RM
Cancer Res; 1995 Mar; 55(5):1105-10. PubMed ID: 7866995
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125--results in immune and clinical responses in breast cancer patients.
Jiang XP; Yang DC; Elliott RL; Head JF
Cancer Biother Radiopharm; 2000 Oct; 15(5):495-505. PubMed ID: 11155821
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical purification and immunological characteristics of ductal carcinoma antigen.
Papsidero LD; Johnson EA
Int J Cancer; 1986 May; 37(5):697-703. PubMed ID: 2422128
[TBL] [Abstract][Full Text] [Related]
6. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.
Singhal A; Fohn M; Hakomori S
Cancer Res; 1991 Mar; 51(5):1406-11. PubMed ID: 1997178
[TBL] [Abstract][Full Text] [Related]
7. Update on vaccine development in AIDS and cancer.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):18-24. PubMed ID: 11362485
[TBL] [Abstract][Full Text] [Related]
8. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
Ito T; Qiu H; Collins JA; Brill AB; Johnson DK; Griffin TW
Cancer Res; 1991 Jan; 51(1):255-60. PubMed ID: 1988087
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
[TBL] [Abstract][Full Text] [Related]
10. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
11. Heterologous immunization, a way out of the problem of monoclonal antibody production against carcinoma antigen 125.
Shojaeian S; Zarnani AH; Jeddi-Tehrani M; Fereidooni F; Torkabadi E; Akhondi MM; Tabatabaei-Panah AS; Allameh A
Iran J Immunol; 2009 Dec; 6(4):174-85. PubMed ID: 20054105
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.
Kramer EL; DeNardo SJ; Liebes L; Noz ME; Kroger L; Glenn SD; Furmanski P; Ceriani R
Adv Exp Med Biol; 1994; 353():181-92. PubMed ID: 7985537
[No Abstract] [Full Text] [Related]
13. A human monoclonal antibody to carbohydrate moiety of carcinoembryonic antigen.
Tsukazaki K; Kuroda K; Mochizuki K; Kubushiro K; Fukuchi T; Kato M; Hashizume S; Nozawa S
Hum Antibodies Hybridomas; 1995; 6(4):145-52. PubMed ID: 8688497
[TBL] [Abstract][Full Text] [Related]
14. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule.
Lloyd KO; Yin BW; Kudryashov V
Int J Cancer; 1997 May; 71(5):842-50. PubMed ID: 9180155
[TBL] [Abstract][Full Text] [Related]
16. Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colon.
Blumenthal RD; Stein R; Sharkey RM; Goldenberg DM; Ong GL; Klein KM; Mattes MJ
Cancer Res; 1996 Aug; 56(15):3508-15. PubMed ID: 8758919
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies.
Hertzog PJ; Pilbrow SJ; Pedersen J; Polglase AL; Lawson M; Linnane AW
Br J Cancer; 1991 Nov; 64(5):799-808. PubMed ID: 1931599
[TBL] [Abstract][Full Text] [Related]
18. Expression of tumor-associated polymorphic epithelial mucin and carcinoembryonic antigen in gastrointestinal carcinoid tumors. Implications for immunodiagnosis and immunotherapy.
Moyana TN; Xiang J
Cancer; 1995 Jun; 75(12):2836-43. PubMed ID: 7539715
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
Griffin TW; Childs LR; FitzGerald DJ; Levin LV
J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
Wong JY; Chu DZ; Williams LE; Liu A; Zhan J; Yamauchi DM; Wilczynski S; Wu AM; Yazaki PJ; Shively JE; Leong L; Raubitschek AA
Cancer Biother Radiopharm; 2006 Apr; 21(2):88-100. PubMed ID: 16706629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
